Propranolol: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Meg Taylor
(subpages)
m (Text replacement - "United States" to "United States of America")
 
Line 20: Line 20:
[[Propranolol]] was developed by James Black who later received the Nobel Prize for this and other work.<ref name="pmid9456487">{{cite journal |author=Stapleton MP |title=Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology |journal=Tex Heart Inst J |volume=24 |issue=4 |pages=336–42 |year=1997 |pmid=9456487 |pmc=325477 |doi= |url= |issn=}}</ref>
[[Propranolol]] was developed by James Black who later received the Nobel Prize for this and other work.<ref name="pmid9456487">{{cite journal |author=Stapleton MP |title=Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology |journal=Tex Heart Inst J |volume=24 |issue=4 |pages=336–42 |year=1997 |pmid=9456487 |pmc=325477 |doi= |url= |issn=}}</ref>


Propranolol was marketed in the [[United States]] by Akrimax Pharms.  Propranolol received approval in the [[United States]] November 13, 1967.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=016418 Drugs@FDA]. U S Food and Drug Administration</ref>
Propranolol was marketed in the [[United States of America]] by Akrimax Pharms.  Propranolol received approval in the [[United States of America]] November 13, 1967.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=016418 Drugs@FDA]. U S Food and Drug Administration</ref>


[[Generic drug|Generic]] propranolol was available October 22, 1985.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=070103 Drugs@FDA]. U S Food and Drug Administration</ref>
[[Generic drug|Generic]] propranolol was available October 22, 1985.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=070103 Drugs@FDA]. U S Food and Drug Administration</ref>

Latest revision as of 14:07, 2 February 2023

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.
Propranolol.png
propranolol
IUPAC name:
Synonyms:
Formula:

 Uses: hypertention;angina pectoris

 Properties: lipophilic

 Hazards: see side effects & drug interactions

Mass (g/mol): CAS #:


In medicine, propranolol is "a widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for myocardial infarction; arrhythmia; angina pectoris; hypertension; hyperthyroidism; migraine; pheochromocytoma; and anxiety but adverse effects instigate replacement by newer drugs."[1]

History

Propranolol was developed by James Black who later received the Nobel Prize for this and other work.[2]

Propranolol was marketed in the United States of America by Akrimax Pharms. Propranolol received approval in the United States of America November 13, 1967.[3]

Generic propranolol was available October 22, 1985.[4]

Metabolism

Propranolol is metabolized in the liver by several isoenzymes of cytochrome P-450.

External links

The most up-to-date information about Propranolol and other drugs can be found at the following sites.


References

  1. Anonymous (2024), Propranolol (English). Medical Subject Headings. U.S. National Library of Medicine.
  2. Stapleton MP (1997). "Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology". Tex Heart Inst J 24 (4): 336–42. PMID 9456487. PMC 325477[e]
  3. Drugs@FDA. U S Food and Drug Administration
  4. Drugs@FDA. U S Food and Drug Administration